Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Mast Cell Activation Syndrome in Patients With Ehlers Danlos Hypermobile Syndrome With Digestive Disorders

NCT05382169 is registered in ClinicalTrials.gov with Lille Catholic University as lead sponsor.

NCT NCT05382169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05382169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Mast Cell Activation Syndrome in Patients With Ehlers Danlos Hypermobile Syndrome With Digestive Disorders
Lead sponsor
Lille Catholic University
Phase
Observational
Overall status
Unknown status
Start date
September 28, 2022
Completion date
March 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ehlers danlos hypermobile syndrome